N-[(3R,6S,9S,12R,16S,19S)-16-[(2S)-2-carbamoylpyrrolidine-1-carbonyl]-9-[4-(dimethylamino)butyl]-6-(1H-indol-3-ylmethyl)-2,5,8,11,14,18-hexaoxo-3,12-bis(sulfanylmethyl)-1,4,7,10,13,17-hexazacyclotricos-19-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide

C47H70N12O11S2 — CID 140733695

IUPACN-[(3R,6S,9S,12R,16S,19S)-16-[(2S)-2-carbamoylpyrrolidine-1-carbonyl]-9-[4-(dimethylamino)butyl]-6-(1H-indol-3-ylmethyl)-2,5,8,11,14,18-hexaoxo-3,12-bis(sulfanylmethyl)-1,4,7,10,13,17-hexazacyclotricos-19-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide
SMILESCN(C)CCCC[C@@H]1NC(=O)[C@H](CS)NC(=O)C[C@@H](C(=O)N2CCC[C@H]2C(N)=O)NC(=O)[C@@H](NC(=O)C2CCCN2C(=O)CO)CCCCNC(=O)[C@H](CS)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O
InChIInChI=1S/C47H70N12O11S2/c1-57(2)18-8-6-14-30-42(65)54-32(21-27-23-50-29-12-4-3-11-28(27)29)44(67)56-34(25-71)41(64)49-17-7-5-13-31(53-46(69)37-16-10-19-58(37)39(62)24-60)43(66)55-33(22-38(61)51-35(26-72)45(68)52-30)47(70)59-20-9-15-36(59)40(48)63/h3-4,11-12,23,30-37,50,60,71-72H,5-10,13-22,24-26H2,1-2H3,(H2,48,63)(H,49,64)(H,51,61)(H,52,68)(H,53,69)(H,54,65)(H,55,66)(H,56,67)/t30-,31-,32-,33-,34-,35-,36-,37?/m0/s1
InChIKeyHENQQXYWUCVJQO-GOCTXPOLSA-N
MW1043.28 g/mol
LogP-2.64
Rot. Bonds14

About N-[(3R,6S,9S,12R,16S,19S)-16-[(2S)-2-carbamoylpyrrolidine-1-carbonyl]-9-[4-(dimethylamino)butyl]-6-(1H-indol-3-ylmethyl)-2,5,8,11,14,18-hexaoxo-3,12-bis(sulfanylmethyl)-1,4,7,10,13,17-hexazacyclotricos-19-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide

N-[(3R,6S,9S,12R,16S,19S)-16-[(2S)-2-carbamoylpyrrolidine-1-carbonyl]-9-[4-(dimethylamino)butyl]-6-(1H-indol-3-ylmethyl)-2,5,8,11,14,18-hexaoxo-3,12-bis(sulfanylmethyl)-1,4,7,10,13,17-hexazacyclotricos-19-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide (PubChem CID 140733695) has the molecular formula C47H70N12O11S2 and a molecular weight of 1043.28 g/mol. Its IUPAC name is N-[(3R,6S,9S,12R,16S,19S)-16-[(2S)-2-carbamoylpyrrolidine-1-carbonyl]-9-[4-(dimethylamino)butyl]-6-(1H-indol-3-ylmethyl)-2,5,8,11,14,18-hexaoxo-3,12-bis(sulfanylmethyl)-1,4,7,10,13,17-hexazacyclotricos-19-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide.

Molecular Properties

Compound NameN-[(3R,6S,9S,12R,16S,19S)-16-[(2S)-2-carbamoylpyrrolidine-1-carbonyl]-9-[4-(dimethylamino)butyl]-6-(1H-indol-3-ylmethyl)-2,5,8,11,14,18-hexaoxo-3,12-bis(sulfanylmethyl)-1,4,7,10,13,17-hexazacyclotricos-19-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide
PubChem CID140733695
Molecular FormulaC47H70N12O11S2
Molecular Weight1043.28 g/mol
Exact Mass1042.47
IUPAC NameN-[(3R,6S,9S,12R,16S,19S)-16-[(2S)-2-carbamoylpyrrolidine-1-carbonyl]-9-[4-(dimethylamino)butyl]-6-(1H-indol-3-ylmethyl)-2,5,8,11,14,18-hexaoxo-3,12-bis(sulfanylmethyl)-1,4,7,10,13,17-hexazacyclotricos-19-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide
SMILESCN(C)CCCC[C@@H]1NC(=O)[C@H](CS)NC(=O)C[C@@H](C(=O)N2CCC[C@H]2C(N)=O)NC(=O)[C@@H](NC(=O)C2CCCN2C(=O)CO)CCCCNC(=O)[C@H](CS)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O
InChIInChI=1S/C47H70N12O11S2/c1-57(2)18-8-6-14-30-42(65)54-32(21-27-23-50-29-12-4-3-11-28(27)29)44(67)56-34(25-71)41(64)49-17-7-5-13-31(53-46(69)37-16-10-19-58(37)39(62)24-60)43(66)55-33(22-38(61)51-35(26-72)45(68)52-30)47(70)59-20-9-15-36(59)40(48)63/h3-4,11-12,23,30-37,50,60,71-72H,5-10,13-22,24-26H2,1-2H3,(H2,48,63)(H,49,64)(H,51,61)(H,52,68)(H,53,69)(H,54,65)(H,55,66)(H,56,67)/t30-,31-,32-,33-,34-,35-,36-,37?/m0/s1
InChIKeyHENQQXYWUCVJQO-GOCTXPOLSA-N
XLogP-2.64
TPSA326.67 Ų
H-Bond Donors12
H-Bond Acceptors14
Rotatable Bonds14
Heavy Atoms72
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001043.28
LogP ≤ 5-2.64
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'thiol_2', 'substructure': 'N/A'}

Analyze N-[(3R,6S,9S,12R,16S,19S)-16-[(2S)-2-carbamoylpyrrolidine-1-carbonyl]-9-[4-(dimethylamino)butyl]-6-(1H-indol-3-ylmethyl)-2,5,8,11,14,18-hexaoxo-3,12-bis(sulfanylmethyl)-1,4,7,10,13,17-hexazacyclotricos-19-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(3R,6S,9S,12R,16S,19S)-16-[(2S)-2-carbamoylpyrrolidine-1-carbonyl]-9-[4-(dimethylamino)butyl]-6-(1H-indol-3-ylmethyl)-2,5,8,11,14,18-hexaoxo-3,12-bis(sulfanylmethyl)-1,4,7,10,13,17-hexazacyclotricos-19-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide?
The IUPAC name of N-[(3R,6S,9S,12R,16S,19S)-16-[(2S)-2-carbamoylpyrrolidine-1-carbonyl]-9-[4-(dimethylamino)butyl]-6-(1H-indol-3-ylmethyl)-2,5,8,11,14,18-hexaoxo-3,12-bis(sulfanylmethyl)-1,4,7,10,13,17-hexazacyclotricos-19-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide (CID 140733695) is N-[(3R,6S,9S,12R,16S,19S)-16-[(2S)-2-carbamoylpyrrolidine-1-carbonyl]-9-[4-(dimethylamino)butyl]-6-(1H-indol-3-ylmethyl)-2,5,8,11,14,18-hexaoxo-3,12-bis(sulfanylmethyl)-1,4,7,10,13,17-hexazacyclotricos-19-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide.
What is the SMILES notation for N-[(3R,6S,9S,12R,16S,19S)-16-[(2S)-2-carbamoylpyrrolidine-1-carbonyl]-9-[4-(dimethylamino)butyl]-6-(1H-indol-3-ylmethyl)-2,5,8,11,14,18-hexaoxo-3,12-bis(sulfanylmethyl)-1,4,7,10,13,17-hexazacyclotricos-19-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide?
The canonical SMILES for N-[(3R,6S,9S,12R,16S,19S)-16-[(2S)-2-carbamoylpyrrolidine-1-carbonyl]-9-[4-(dimethylamino)butyl]-6-(1H-indol-3-ylmethyl)-2,5,8,11,14,18-hexaoxo-3,12-bis(sulfanylmethyl)-1,4,7,10,13,17-hexazacyclotricos-19-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide is CN(C)CCCC[C@@H]1NC(=O)[C@H](CS)NC(=O)C[C@@H](C(=O)N2CCC[C@H]2C(N)=O)NC(=O)[C@@H](NC(=O)C2CCCN2C(=O)CO)CCCCNC(=O)[C@H](CS)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O.
What is the InChIKey of N-[(3R,6S,9S,12R,16S,19S)-16-[(2S)-2-carbamoylpyrrolidine-1-carbonyl]-9-[4-(dimethylamino)butyl]-6-(1H-indol-3-ylmethyl)-2,5,8,11,14,18-hexaoxo-3,12-bis(sulfanylmethyl)-1,4,7,10,13,17-hexazacyclotricos-19-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide?
The InChIKey is HENQQXYWUCVJQO-GOCTXPOLSA-N. The full InChI is InChI=1S/C47H70N12O11S2/c1-57(2)18-8-6-14-30-42(65)54-32(21-27-23-50-29-12-4-3-11-28(27)29)44(67)56-34(25-71)41(64)49-17-7-5-13-31(53-46(69)37-16-10-19-58(37)39(62)24-60)43(66)55-33(22-38(61)51-35(26-72)45(68)52-30)47(70)59-20-9-15-36(59)40(48)63/h3-4,11-12,23,30-37,50,60,71-72H,5-10,13-22,24-26H2,1-2H3,(H2,48,63)(H,49,64)(H,51,61)(H,52,68)(H,53,69)(H,54,65)(H,55,66)(H,56,67)/t30-,31-,32-,33-,34-,35-,36-,37?/m0/s1.
What are the key properties of N-[(3R,6S,9S,12R,16S,19S)-16-[(2S)-2-carbamoylpyrrolidine-1-carbonyl]-9-[4-(dimethylamino)butyl]-6-(1H-indol-3-ylmethyl)-2,5,8,11,14,18-hexaoxo-3,12-bis(sulfanylmethyl)-1,4,7,10,13,17-hexazacyclotricos-19-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide?
N-[(3R,6S,9S,12R,16S,19S)-16-[(2S)-2-carbamoylpyrrolidine-1-carbonyl]-9-[4-(dimethylamino)butyl]-6-(1H-indol-3-ylmethyl)-2,5,8,11,14,18-hexaoxo-3,12-bis(sulfanylmethyl)-1,4,7,10,13,17-hexazacyclotricos-19-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide has a molecular weight of 1043.28 g/mol, XLogP of -2.64, 14 rotatable bonds, 12 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3R,6S,9S,12R,16S,19S)-16-[(2S)-2-carbamoylpyrrolidine-1-carbonyl]-9-[4-(dimethylamino)butyl]-6-(1H-indol-3-ylmethyl)-2,5,8,11,14,18-hexaoxo-3,12-bis(sulfanylmethyl)-1,4,7,10,13,17-hexazacyclotricos-19-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide is sourced from PubChem (CID 140733695), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).